AU4104093A - Method and compositions for treatment of pyonecrotic processes - Google Patents

Method and compositions for treatment of pyonecrotic processes

Info

Publication number
AU4104093A
AU4104093A AU41040/93A AU4104093A AU4104093A AU 4104093 A AU4104093 A AU 4104093A AU 41040/93 A AU41040/93 A AU 41040/93A AU 4104093 A AU4104093 A AU 4104093A AU 4104093 A AU4104093 A AU 4104093A
Authority
AU
Australia
Prior art keywords
pyonecrotic
compositions
processes
treatment
pyonecrotic processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41040/93A
Inventor
Alexander M Gonchar
Rudolf I Salganik
Alexander V Troitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rufeld Inc
Original Assignee
Rufeld Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rufeld Inc filed Critical Rufeld Inc
Publication of AU4104093A publication Critical patent/AU4104093A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
AU41040/93A 1992-04-20 1993-04-15 Method and compositions for treatment of pyonecrotic processes Abandoned AU4104093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87127992A 1992-04-20 1992-04-20
US871279 1992-04-20

Publications (1)

Publication Number Publication Date
AU4104093A true AU4104093A (en) 1993-11-18

Family

ID=25357099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41040/93A Abandoned AU4104093A (en) 1992-04-20 1993-04-15 Method and compositions for treatment of pyonecrotic processes

Country Status (3)

Country Link
AU (1) AU4104093A (en)
MX (1) MX9302286A (en)
WO (1) WO1993020838A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9704137A (en) 1994-12-07 1997-09-30 Novo Nordisk As Polypeptide with reduced allergenicity.
US6008037A (en) * 1996-11-14 1999-12-28 Polymer Technology Corporation Use of water soluble enzyme-polymer conjugates for cleaning contact lenses
IL120909A0 (en) * 1997-05-26 1997-09-30 Lrr & D Ltd Compositions and means for the treatment of burns and other cutaneous traumas
RU2213557C2 (en) * 2001-12-26 2003-10-10 Закрытое акционерное общество "Аксис" Pharmaceutical composition eliciting thrombolytic, anti-inflammatory and cytoprotective properties
AU2003219351A1 (en) * 2003-04-09 2004-11-01 Harold Armando Gomez Torres Topical composition in the form of a gel for treating skin burns
RU2513201C1 (en) * 2013-01-29 2014-04-20 Алексей Леонидович Чарышкин Method for regional lymphotropic therapy of paraproctitis
RU2630668C1 (en) * 2016-07-25 2017-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Substance of proteolithic ferment based on protosubtilin gzh immobilized on chitosan and composition for treatment of purulent-necrotic wounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758425A (en) * 1969-12-02 1971-04-16 Baxter Laboratories Inc STREPTOKINASE CHEMICALLY LINKED TO A CARBOHYDRATE MATRIX (
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4025391A (en) * 1974-06-15 1977-05-24 Director Of National Food Research Institute Preparation of bead-shaped immobilized enzyme
CH596313A5 (en) * 1975-05-30 1978-03-15 Battelle Memorial Institute
JPS5951789A (en) * 1982-09-18 1984-03-26 Wako Pure Chem Ind Ltd Stabilized enzyme
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
AT397723B (en) * 1989-08-21 1994-06-27 Epipharm Allergie Service METHOD FOR PRODUCING RADIO-CONJUGATED POLYMERS AND USE THEREOF
US5145681A (en) * 1990-08-15 1992-09-08 W. R. Grace & Co.-Conn. Compositions containing protease produced by vibrio and method of use in debridement and wound healing

Also Published As

Publication number Publication date
WO1993020838A1 (en) 1993-10-28
MX9302286A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU4214193A (en) Bioadhesive treatment compositions and method of use
AU4995693A (en) Apparatus and method for the treatment of blood
AU3519893A (en) Antitumor compositions and methods of treatment
AU5896194A (en) Anti-diarrheic product and method of treating rotavirus-associated infection
AU2296995A (en) Composition and method for treatment of cmv infection
AU3681095A (en) Method and pharmaceutical composition for prevention and treatment of brain damage
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU8428791A (en) Composition and method for chromating treatment of metal
AU8192691A (en) Method of treatment and compositions therefore
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
GB9218027D0 (en) Novel method of treatment
AU3720293A (en) Method and compositions for treating acne
GB9202196D0 (en) Method of treatment
AU4652393A (en) Plant treating composition and methods of making and using same
AU7379296A (en) Method and composition for treatment of osteoporosis
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
EP0692965A4 (en) Method and composition for treatment of osteoporosis
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
AU637568B3 (en) Method and composition for treatment of metals
GB9201391D0 (en) Method of treatment
AU5015493A (en) Method of treating asthma
AU6505694A (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
AU6157990A (en) Method and composition for treatment of hyperphosphatemia
SG66305A1 (en) Composition and method for treatment of phoshated surfaces